6 Analysts Have This to Say About Ventyx Biosciences
Portfolio Pulse from Benzinga Insights
In the last quarter, 6 analysts rated Ventyx Biosciences (NASDAQ:VTYX) with 2 bullish and 4 somewhat bullish ratings. The average price target is $61.5, compared to the current price of $34.78, implying an upside. The average price target has decreased by 5.38% from the previous average of $65.00.
June 14, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ventyx Biosciences (NASDAQ:VTYX) received 2 bullish and 4 somewhat bullish ratings from 6 analysts, with an average price target of $61.5, implying an upside from the current price of $34.78.
The 6 analysts' ratings for Ventyx Biosciences are mostly positive, with 2 bullish and 4 somewhat bullish ratings. The average price target of $61.5 is significantly higher than the current price of $34.78, indicating a potential upside. This positive sentiment from analysts could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100